<SEC-DOCUMENT>0001654954-17-011402-index.html : 20171207
<SEC-HEADER>0001654954-17-011402.hdr.sgml : 20171207
<ACCEPTANCE-DATETIME>20171207165613
ACCESSION NUMBER:		0001654954-17-011402
CONFORMED SUBMISSION TYPE:	S-1/A
PUBLIC DOCUMENT COUNT:		7
FILED AS OF DATE:		20171207
DATE AS OF CHANGE:		20171207

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			VistaGen Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001411685
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				205093315
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		S-1/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-221009
		FILM NUMBER:		171245340

	BUSINESS ADDRESS:	
		STREET 1:		343 ALLERTON AVENUE
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		650-577-3600

	MAIL ADDRESS:	
		STREET 1:		343 ALLERTON AVENUE
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Excaliber Enterprises, Ltd.
		DATE OF NAME CHANGE:	20070906
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1/A
<SEQUENCE>1
<FILENAME>vtgns1am12017.htm
<DESCRIPTION>S-1/A
<TEXT>
Document 1 - file: vtgns1am12017.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ex1-1.htm
<DESCRIPTION>FORM OF UNDERWRITING AGREEMENT
<TEXT>
Document 2 - file: ex1-1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>3
<FILENAME>ex4-1.htm
<DESCRIPTION>FORM OF WARRANT
<TEXT>
Document 3 - file: ex4-1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>4
<FILENAME>ex5-1.htm
<DESCRIPTION>OPINION ON LEGALITY
<TEXT>
Document 4 - file: ex5-1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>5
<FILENAME>ex23-2.htm
<DESCRIPTION>CONSENTS OF EXPERTS AND COUNSEL
<TEXT>
Document 5 - file: ex23-2.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>dlg.jpg
<DESCRIPTION>IMAGE
<TEXT>
Document 6 - file: dlg.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>vtgn.jpg
<DESCRIPTION>IMAGE
<TEXT>
Document 7 - file: vtgn.jpg

</DOCUMENT>
</SEC-DOCUMENT>